NCT00411411View on ClinicalTrials.gov

Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

March 31, 2009

Conditions
Type 2 Diabetes
Interventions
DRUG

Januvia

200 mg t.i.d

DRUG

Placebo

Placebo

Trial Locations (1)

2900

Gentofte Hospital, Hellerup

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT00411411 - Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter